U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

Substance Class Protein
Created
by admin
on Tue Apr 01 22:25:59 GMT 2025
Edited
by admin
on Tue Apr 01 22:25:59 GMT 2025
Protein Type RECEPTOR
Protein Sub Type
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
4R3XO922WS
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
N-methyl-D-aspartate receptor
Preferred Name English
NMDA RECEPTOR
Common Name English
NMDAR
Common Name English
Code System Code Type Description
FDA UNII
4R3XO922WS
Created by admin on Tue Apr 01 22:25:59 GMT 2025 , Edited by admin on Tue Apr 01 22:25:59 GMT 2025
PRIMARY
WIKIPEDIA
NMDA receptor antagonist
Created by admin on Tue Apr 01 22:25:59 GMT 2025 , Edited by admin on Tue Apr 01 22:25:59 GMT 2025
PRIMARY
Glycosylation Type HUMAN
Glycosylation Link Type Site
N 1_43
N 1_185
N 1_221
N 1_258
N 1_282
N 1_332
N 1_350
N 1_422
N 1_453
N 1_473
N 1_753
N 2_43
N 2_185
N 2_221
N 2_258
N 2_282
N 2_332
N 2_350
N 2_422
N 2_453
N 2_473
N 2_753
N 3_53
N 3_318
N 3_358
N 3_421
N 3_519
N 3_592
N 3_665
N 3_864
N 3_881
N 3_889
N 3_924
N 3_967
N 3_1019
N 3_1116
N 3_1188
N 3_1375
N 4_48
N 4_315
N 4_322
N 4_418
N 4_465
N 4_516
N 4_589
N 4_662
N 4_866
N 4_884
N 4_889
N 4_1149
N 4_1174
N 4_1198
N 4_1249
N 4_1326
N 4_1424
N 4_1440
Related Record Type Details
INHIBITOR -> TARGET
INHIBITOR -> TARGET
INHIBITOR -> TARGET
Channel blocker
UNCOMPETITIVE
Ki
INHIBITOR -> TARGET
INHIBITOR -> TARGET
NON-COMPETITIVE
Ki
INHIBITOR -> TARGET
INHIBITOR -> TARGET
INHIBITOR -> TARGET
INHIBITOR -> TARGET
INHIBITOR -> TARGET
Blocks glutamate binding.
COMPETITIVE INHIBITOR
INHIBITOR -> TARGET
INHIBITOR -> TARGET
COMPETITIVE INHIBITOR
INHIBITOR -> TARGET
INHIBITOR -> TARGET
WEAK INHIBITOR->TARGET
Rat. Prodrug of dextrorphan, which is the actual mediator of most of its dissociative effects through acting as a more potent NMDA receptor antagonist than dextromethorphan itself.
Ki
INHIBITOR -> TARGET
Binds to glutamate site
COMPETITIVE INHIBITOR
INHIBITOR -> TARGET
INHIBITOR -> TARGET
COMPETITIVE INHIBITOR
INHIBITOR -> TARGET
INHIBITOR -> TARGET
INHIBITOR -> TARGET
INHIBITOR -> TARGET
INHIBITOR -> TARGET
INHIBITOR -> TARGET
MODULATOR->TARGET
AGONIST -> TARGET
INHIBITOR -> TARGET
PARTIAL AGONIST->TARGET
INHIBITOR -> TARGET
INHIBITOR -> TARGET
INHIBITOR -> TARGET
MODULATOR->TARGET
POSITIVE ALLOSTERIC MODULATOR (PAM)->TARGET
positive allosteric modulator of NMDA receptors
ALLOSTERIC
INHIBITOR -> TARGET
Competes with glutamate
COMPETITIVE INHIBITOR
INHIBITOR -> TARGET
Channel blocker
UNCOMPETITIVE
Ki
INHIBITOR -> TARGET
Noncompetitive antagonists at the NMDA receptor via binding to an allosteric site distinct from the glutamate-binding site.This receptor is a critical modulator of CNS neurotransmission, and excitability changes produced by ketamine antagonism may explain the drug’s anesthetic and analgesic properties.
ALLOSTERIC INHIBITOR
Ki
INHIBITOR -> TARGET
INHIBITOR -> TARGET
INHIBITOR -> TARGET
INHIBITOR -> TARGET
COMPETITIVE INHIBITOR
INHIBITOR -> TARGET
Active as an NMDA receptor antagonist in the central nervous system at roughly 30 times the potency of the "flagship" of its class, ketamine.
Ki
INHIBITOR -> TARGET
NON-COMPETITIVE
IC50
INHIBITOR -> TARGET
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL